At JDS THERAPEUTICS, we leverage our extensive experience in mineral science to target major diseases with unmet medical needs. We develop products that address these health issues and bring them to market via our Bonafide and Nutrition 21 business units. Nutrition 21, which focuses on wellness and performance-related ingredients, is the world’s leader in chromium complexes and technologies.

Since 2011, JDS THERAPEUTICS has conducted more than 20 preclinical and clinical studies on products currently in our pipeline. We are engaged in an ongoing mission to develop and commercialize novel ingredients, supplements, and drugs in the areas of sports nutrition and women’s health.